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Surgical treatment of internal carotid artery
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Purpose: Nonoperative treatment of recent internal carotid artery (ICA) occlusion is associated with increased recurrent
stroke rates. We analyzed our results of carotid endarterectomy (CEA) for treatment of symptomatic recent ICA occlusion
to evaluate its feasibility, safety, and outcomes.
Methods: From 1990 to 2002, all patients with transient ischemic attack (TIA), amaurosis fugax, and minor stroke
underwent duplex ultrasound (US) scanning and arteriography to confirm the diagnosis of ICA occlusion. Within 2
weeks of symptom onset, patients underwent operative exploration with attempted CEA. ICA occlusion was detected at
preoperative angiography and confirmed at surgery. Patients with extensive ICA plaque not amenable to endarterectomy
underwent external CEA with ICA ligation.
Results: Over 12 years, 87 patients with symptomatic ICA occlusion underwent 90 operations for ICA exploration. In 30
patients (18 men, 12 women) with TIA (45%), amaurosis fugax (19%), or minor stroke (36%), CEA to treat ICA
occlusion was technically successful. There was 1 postoperative stroke, 2 asymptomatic internal carotid occlusions, and no
restenoses (mean follow-up, 26 months; range, 1-93 months). In 57 patients (37 men, 20 women) with TIA (41%),
amaurosis fugax (27%), or stroke (32%) in whom CEA was unsuccessful, external CEA was performed. In this group there
were no postoperative strokes, 2 asymptomatic external carotid artery occlusions, and 1 restenosis (>70%) (mean
follow-up, 22 months; range, 1-73 months). There were no late strokes in either group.
Conclusion: Operative exploration and endarterectomy to treat symptomatic ICA occlusion is feasible and safe. Patients
with symptomatic ICA occlusion should be considered candidates for CEA. (J Vasc Surg 2003;37:785-8.)
Several randomized trials have validated the use of
carotid endarterectomy (CEA) to treat symptomatic and
asymptomatic hemodynamic significant carotid stenosis.1,2
However, treatment of symptomatic internal carotid artery
(ICA) occlusion remains controversial. Despite optimal
medical management, ICA occlusion is associated with
increased ipsilateral recurrent stroke rates of 6% to 20% per
year.4-8 Furthermore, in the presence of substantial con-
tralateral carotid artery stenosis, ICA occlusion doubles the
risk for subsequent contralateral stroke.9 Although earlier
reports of carotid revascularization to treat ICA occlusion
indicated dismal improvement in neurologic function,10,11
Kasper et al12 have recently published their experience with
beneficial effects of CEA in patients with ICA occlusion. To
evaluate the feasibility and outcomes of CEA for treatment
of acute and subacute symptomatic ICA occlusion, we
analyzed our 12-year experience.
METHODS
We reviewed data for all patients undergoing surgical
treatment of acute and subacute (within 14 days of symp-
tom onset) symptomatic ICA occlusion between 1990 and
2002 from a prospectively collected vascular surgery regis-
try. Preoperative diagnosis of ICA occlusion was confirmed
with color-flow duplex US and arteriography (conventional
digital subtraction or magnetic resonance). Patients were
evaluated preoperatively by a consultant neurologist and
the vascular surgery service. All patients with ICA occlusion
had symptoms referable to the ipsilateral cerebral hemi-
sphere and underwent surgical carotid revascularization
within 14 days of symptom onset. Patient exclusion criteria
included ICA occlusion after CEA, trauma, and severe
neurologic deficit and obtundation (modified Rankin score
4).13 Patients with ICA occlusion who had a patent ICA
at the time of operative exploration were also excluded
from the study.
Preoperative evaluation included computed tomogra-
phy (CT) or magnetic resonance imaging (MRI) to evalu-
ate the presence and severity of stroke. Regional cervical
block (superficial and deep) was the preferred anesthetic,
and general anesthesia with endotracheal intubation was
selectively used in patients who did not tolerate cervical
block. Carotid shunting was primarily used when neuro-
logic deterioration occurred after placement of clamps, and
was left to the discretion of the vascular surgeon. In all
patients, ICA occlusion was confirmed at surgical explora-
tion, and CEA was attempted with either eversion or the
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standard longitudinal technique. These techniques have
been previously described.3,14 All patients received sys-
temic heparin during surgery (intravenous heparin, 30
U/kg). After CEA, when thrombus was present in the
distal ICA, it was gently grasped and extracted with forceps.
When ICA backbleeding was not observed, a No. 2 Fogarty
embolectomy catheter was carefully used for sequential
ICA thrombectomy by advancing the catheter in 2 cm
increments to a maximum of 10 cm. Patients with extensive
ICA plaque not amenable to endarterectomy underwent
external CEA with eversion or standard longitudinal tech-
niques and ligation of the ICA. In patients with concomi-
tant severe stenosis or occlusion of the proximal ipsilateral
common carotid artery, adjunctive bypass from contralat-
eral carotid, subclavian, or axillary arteries was performed to
restore flow to the ipsilateral carotid bifurcation.
Postoperatively all patients remained in the post-anes-
thesia care unit for at least 4 to 6 hours, and their vital signs
were monitored continuously. When hemodynamic param-
eters were stable, patients were transferred to the surgical
floor. If hemodynamic or neurologic status was question-
able, patients were transferred to a monitored bed in the
intensive care unit. Any change in neurologic status was
reevaluated with carotid duplex ultrasound scanning, head
CT, or MRI. Postoperatively, all patients were given aspirin
therapy at a dose of 81 mg/d. Routine postoperative
surveillance included duplex US scanning at 1 and 6
months and yearly thereafter.
Based on a prospectively compiled vascular surgery
registry, patients with symptomatic ICA occlusion were
divided into two groups. Group 1 included patients who
underwent internal and external CEA, and group II in-
cluded patients not amenable to internal CEA who under-
went external CEA only. All statistical tests were two-tailed,
and P  .05 was considered to represent statistical signifi-
cance.
RESULTS
Over 12 years, 90 carotid artery exploratory operations
were performed at our institution in patients with acute and
subacute symptomatic ICA occlusion. Three patients had
symptoms referable to bilateral ICA occlusion. Of these, 31
(34%) patients underwent internal and external CEA
(group 1) and 59 (66%) underwent external CEA only
(group 2). One patient had common carotid artery occlu-
sion and was excluded. Demographics, preoperative symp-
toms, and comorbid conditions for groups 1 and 2 are
detailed in Table I. In groups 1 and 2, patients had symp-
toms of transient cerebral ischemic attack (TIA) (group 1,
45%; group 2, 41%), amaurosis fugax (group 1, 19%; group
2, 27%), and stroke (group 1, 36%; group 2, 32%). Comor-
bid conditions were similar except that substantially more
patients in group 2 had a history of diabetes mellitus and
cigarette smoking. Eighty-seven percent of group 1 pa-
tients and 94% of group 2 patients underwent carotid
revascularization under cervical block; the remainder re-
quired general anesthesia. Carotid shunting was used in
group 1 patients (n 2, 6%). Eversion CEA was performed
in 21 patients (68%) in group 1 and 43 patients (73%) in
group 2. Standard longitudinal CEA was performed in 10
patients (32%) in group 1 and 16 patients (22%) in group 2
(Table II). Concomitant adjunctive procedures to improve
inflow included carotid-carotid bypass (group 1, 3%; group
2, 3%), subclavian-carotid bypass (group 1, 7%; group 2,
2%), and axillary-carotid bypass (group 1, 3%; group 2, 0%)
(Table III).
Postoperative complications included neck hematoma
(group 1, 7%; group 2, 2%), TIA (group 1, 3%; group 2,
0%), stroke (group 1, 3%; group 2, 0%), and myocardial
infarction (group 1, 3%; group 2, 2%). The only stroke in
Table I. Demographics
Group 1 Group 2
n % n %
Patients
Men 18 60 37 65
Women 12 40 20 35
Mean age (y) 69 66
Age range (y) 50-91 40-84
Preoperative symptoms
Transient ischemic attack 14 45 24 41
Amaurosis fugax 6 19 16 27
Stroke 11 36 19 32
Comorb conditions
Coronary artery disease 9 33 12 20
Hypertension 7 26 14 24
Diabetes mellitus* 1 3 13 23
Smoking 6 20 29 51
*P  .05.
Table II. Operative events
Group 1 Group 2
n % n %
Eversion CEA 21 68 43 73
Standard longitudinal CEA 10 32 16 27
Shunt use 2 6 0 0
Regional anesthesia 27 87 56 95
General anesthesia 4 13 3 5
CEA, Carotid endarterectomy.
Table III. Adjunctive procedures to improve inflow
Group 1 Group 2
n % n %
Carotid-carotid bypass 1 3 2 3
Subclavian-carotid bypass 2 7 1 2
Axillary-carotid bypass 1 3 0
Catheter-assisted distal
ICA thrombectomy
5 16 0
Catheter-assisted distal
ECA thrombectomy
2 7 0
Total 11 36 3 5
ICA, Internal carotid artery; ECA, external carotid artery.
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group 1 occurred in a patient with acute stroke who had
hemorrhagic conversion of a bland infarct. Postoperative
carotid artery occlusions, immediate (group 1, 3%; group 2,
2%) as well as late (group 1, 3%; group 2, 2%), did not result
in any new clinical neurologic deficits (Table IV). In pa-
tients with stroke there was improvement in 64% (7 of 11)
in group 1 and none in group 2. Mean (SE) hospital stay
for group 1 was 7.25  0.29 days (range, 2-42 days) in
group 1 and 4.82  0.10 days (range, 1-25 days) in group
2.
No patients in group 1 and 1 patient in group 2 died in
the perioperative period (30 days). Two patients (7%) in
group 1 and 6 patients (11%) in group 2 died of causes
unrelated to carotid revascularization over a mean of 24
months (range, 2-51 months) (Table IV). Causes of death
were myocardial infarction (n  2) in group 1, and myo-
cardial infarction (n  4), respiratory failure (n  1), and
colon cancer (n 1) in group 2. Life table actuarial analysis
indicated stroke-free survival of 91% at 1 and 3 years and
71% at 5 years in group 1, and 92% at 1 year, 86% at 3 years,
and 60% at 5 years in group 2 (Tables V and VI).
DISCUSSION
Since earlier results of carotid revascularization in the
setting of acute and subacute occlusion were associated
with dismal outcomes, currently accepted treatment op-
tions for symptomatic ICA occlusion are geared toward
optimizing medical therapy with antiplatelet or anticoagu-
lant agents.9-11 However, stroke rates as high as 20% per
year have been reported in patients who receive nonopera-
tive management.7 Our results indicate that in selected
patients internal CEA for treatment of acute and subacute
symptomatic ICA occlusion is feasible and associated with
limited morbidity, including ipsilateral and contralateral
stroke, and mortality. When internal CEA is not feasible
because of extensive chronic occlusion, external CEA can
be performed to increase collateral cerebral perfusion, with
limited morbidity and mortality.
The pathophysiology of stroke after ICA occlusion
depends not only on cerebral hypoperfusion but also on
distal embolization. Emboli can originate from a diseased
external carotid artery or common carotid artery, the prox-
imal stump of an occluded ICA, and the distal end of an
occluded ICA. Medical treatment with anti-platelet and
anticoagulant therapy might help reduce propagation of
thromboemboli. However, without surgical revasculariza-
tion, persistent cerebral hypoperfusion and atherosclerotic
plaques can lead to increased risk for recurrent stroke. CEA
not only increases perfusion to ipsilateral and contralateral
cerebral hemispheres, but also eliminates a source of embo-
lization.15,16 After ICA occlusion, reduced cerebral blood
flow has been reported by several investigators based on
measurements of cerebral blood flow by stable xenon CT
techniques.17-19
Our algorithm for management of patients with symp-
toms of TIA, amaurosis fugax, and stroke includes evalua-
tion with head CT and carotid duplex US scanning. In cases
of ipsilateral ICA occlusion a four-vessel carotid-cerebral
arteriogram is obtained to confirm the diagnosis. In the
absence of hemorrhagic cerebral infarct and overt signs of
major stroke and obtundation (Rankin class 4), ipsilateral
carotid artery exploration is performed with attempted ICA
thromboendarterectomy. In the absence of backbleeding
from the distal ICA, catheter-directed sequential throm-
bectomy is performed in 2 cm increments with a No. 2
Fogarty catheter, and is limited to the proximal 10 cm of
the ICA. In cases of chronic occlusion or extensive disease
prohibiting ICA thromboendarterectomy, the ICA is su-
ture ligated and external CEA is performed. Only one
patient had stroke after internal CEA. A review of preoper-
ative head CT scans indicated the presence of a small
hemorrhagic infarct that was missed before CEA. Earlier
recognition of the hemorrhagic infarct might have resulted
Table IV. Morbidity and mortality
Group 1 Group 2
n % n %
Hematoma 2 7 1 2
Transient ischemic attack 1 3 0
Stroke 1 3 0
Myocardial infarction 1 3 1 2
Occlusion 30 days 1 3 1 2
Occlusion 30 days 1 3 1 2
Death 30 days 0 1 2
Death 30 days 2 7 6 11
Table V. Stroke-free survival after internal carotid artery
thromboendarterectomy
Time
(mo)
At
risk
Death or
stroke
Interval
survival
Cumulative
survival
Standard
error (%)
0-1 30 1 0.963 0.963 3.6
2-12 23 1 0.944 0.910 6.4
13-24 11 0 1.000 0.910 8.4
25-36 9 0 1.000 0.910 10.0
37-48 6 0 1.000 0.910 11.7
49-60 5 1 0.778 0.707 18.0
61-72 3 0 1.000 0.707 24.2
73-84 2 0 1.000 0.707 31.2
85-96 1 0 1.000 0.707 54.1
Table VI. Cumulative stroke-free survival after external
carotid artery thromboendarterectomy
Time
(mo)
At
risk
Death or
stroke
Interval
survival
Cumulative
survival
Standard
error (%)
0-1 57 1 0.981 0.981 1.8
2-12 45 2 0.941 0.923 3.8
13-24 21 0 1.000 0.923 5.6
25-36 17 1 0.931 0.859 7.8
37-48 11 3 0.700 0.602 11.4
49-60 6 0 1.000 0.602 15.5
61-72 4 0 1.000 0.602 19.0
73-84 1 0 1.000 0.602 38.0
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in better patient selection for CEA and prevented stroke in
this patient. Our routine treatment of hemorrhagic stroke is
conservative and nonsurgical. Rob10 analyzed the results of
carotid revascularization to treat ICA occlusion and indi-
cated hemorrhagic infarct to be the leading cause of death.
Our experience suggests that after careful selection of
patients, 34% with acute or subacute ICA occlusion are
amenable to internal CEA, with limited morbidity and
mortality. Furthermore, external CEA can be accomplished
in patients not amenable to internal CEA (66%), with
similar perioperative morbidity and mortality. Stroke-free
survival for patients undergoing internal CEA (91% at 3
years and 71% at 5 years) was improved compared with that
in patients not amenable to internal CEA and requiring
external CEA only (85% at 3 years and 60% at 5 years).
These differences were not, however, statistically signifi-
cant.
The feasibility, safety, and improved outcomes of CEA
for ICA occlusion have been supported by several other
investigators as well. Welling et al20 reviewed their data for
24 patients undergoing carotid revascularization to treat
symptomatic ICA occlusion and reported a 63% technical
success rate and 0% mortality. Surgery in these patients was
performed up to 3 weeks after onset of clinical symptoms.
In a more recent report from the same center, Kasper et al12
reported the outcome for CEA to treat ICA occlusion
within 8 days of clinical presentation. In their group of 29
patients, successful restoration of ICA flow was possible in
83%, with 3% mortality.12 Improvement in results in this
later series was attributed to better patient selection. In
comparison with this last report, we found in the present
study that restoration of ICA flow was possible in only one
third of patients. This is no doubt a result of patient
selection, because all patients received treatment within 2
weeks from onset of symptoms. Demographics may also
have a part, inasmuch as there was a predominance of
diabetes and smoking in patients in whom ICA flow could
not be reestablished.
The emphasis of the previously mentioned series deal-
ing with recent ICA occlusion was only to reestablish flow
to the ICA. Over the long term this reduces risk for
stroke.12 In the present study, we found that treatment of
external carotid disease when flow cannot be restored to the
ICA may also increase stroke-free survival, as compared
with natural history data of up to 20% per year risk of
recurrent stroke after nonoperative management of ICA
occlusion.7
In selected patients with recent symptomatic ICA oc-
clusion, internal and external CEA is technically feasible,
with acceptable morbidity and mortality, and improved
5-year stroke- free survival. Careful patient selection on the
basis of neurologic examination and head CT is crucial in
limiting the irreversible complications of hemorrhagic
stroke and death that have been previously reported. A
randomized prospective trial is needed to define the true
natural history of symptomatic ICA occlusion and the
potential benefits of carotid revascularization.
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